Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000333656 | SCV000478378 | uncertain significance | Geleophysic dysplasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022109 | SCV004853303 | uncertain significance | Inborn genetic diseases | 2022-12-19 | criteria provided, single submitter | clinical testing | The c.1198G>A (p.G400S) alteration is located in exon 10 (coding exon 9) of the ADAMTSL2 gene. This alteration results from a G to A substitution at nucleotide position 1198, causing the glycine (G) at amino acid position 400 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |